Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TMS of the Carolinas is a private mental healthcare provider focused on delivering NeuroStar Advanced Transcranial Magnetic Stimulation therapy in North Carolina. Founded in 2020, the company operates outpatient clinics in Charlotte, Raleigh, and Concord and offers FDA-cleared, non-drug, non-invasive treatment primarily for major depressive disorder and treatment-resistant depression, with adjunctive OCD treatment and broader mental health support. Its model is service-based rather than drug-development based, centered on commercial delivery of TMS treatment protocols, psychiatric oversight, and patient support. The business appears to be a regional specialty behavioral health practice rather than a biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TMS of the Carolinas.